Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Robertson

Showing results (21-30 of 228) with videos related to

Pageof 23
Sort By:
Drug Discovery Today|October 27, 2004
Beyond classical meta-analysis: can inadequately reported studies be included?Chris Robertson, Nik Ruzni Nik Idris, Peter Boyle
Epidemics|May 5, 2026
On the simultaneous inference of susceptibility distributions and intervention effects from epidemic curvesIbrahim Mohammed, Chris Robertson, M Gabriela M Gomes
Statistics in Medicine|May 8, 2020
A Bayesian hierarchical approach for multiple outcomes in routinely collected healthcare dataRaymond Carragher, Tanja Mueller, Marion Bennie, et al.
The Lancet Regional Health. Europe|March 17, 2025
Impact of COVID-19 pandemic on elective care backlog trends, recovery efforts, and capacity needs to address backlogs in Scotland (2013-2023): a descriptive analysis and modelling studySyed Ahmar Shah, Karen Jeffrey, Chris Robertson, et al.
JAMA Network Open|September 8, 2022
Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in EnglandVahé Nafilyan, Isobel L Ward, Chris Robertson, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2017
Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studiesTanja Mueller, Samantha Alvarez-Madrazo, Chris Robertson, et al.
The Lancet. Infectious Diseases|April 25, 2022
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative designAziz Sheikh, Steven Kerr, Mark Woolhouse, et al.
Statistics in Medicine|February 28, 2014
Quantifying unrecognised replication present in reports of HIV diagnosesNikolaos Sfikas, David Greenhalgh, Wenwen Huo, et al.
The Lancet. Respiratory Medicine|January 16, 2022
Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort studyTing Shi, Jiafeng Pan, Eleftheria Vasileiou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
The impact of meningococcal serogroup C conjugate vaccine in ScotlandJohn D Mooney, Peter Christie, Chris Robertson, et al.
Pageof 23

Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Drug Discovery Today|October 27, 2004
Beyond classical meta-analysis: can inadequately reported studies be included?Chris Robertson, Nik Ruzni Nik Idris, Peter Boyle
Epidemics|May 5, 2026
On the simultaneous inference of susceptibility distributions and intervention effects from epidemic curvesIbrahim Mohammed, Chris Robertson, M Gabriela M Gomes
Statistics in Medicine|May 8, 2020
A Bayesian hierarchical approach for multiple outcomes in routinely collected healthcare dataRaymond Carragher, Tanja Mueller, Marion Bennie, et al.
The Lancet Regional Health. Europe|March 17, 2025
Impact of COVID-19 pandemic on elective care backlog trends, recovery efforts, and capacity needs to address backlogs in Scotland (2013-2023): a descriptive analysis and modelling studySyed Ahmar Shah, Karen Jeffrey, Chris Robertson, et al.
JAMA Network Open|September 8, 2022
Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in EnglandVahé Nafilyan, Isobel L Ward, Chris Robertson, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2017
Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studiesTanja Mueller, Samantha Alvarez-Madrazo, Chris Robertson, et al.
The Lancet. Infectious Diseases|April 25, 2022
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative designAziz Sheikh, Steven Kerr, Mark Woolhouse, et al.
Statistics in Medicine|February 28, 2014
Quantifying unrecognised replication present in reports of HIV diagnosesNikolaos Sfikas, David Greenhalgh, Wenwen Huo, et al.
The Lancet. Respiratory Medicine|January 16, 2022
Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort studyTing Shi, Jiafeng Pan, Eleftheria Vasileiou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
The impact of meningococcal serogroup C conjugate vaccine in ScotlandJohn D Mooney, Peter Christie, Chris Robertson, et al.
Pageof 23